🔜 Coming soon!
Get ready to meet the touchCARDIO Future Leaders 2026! 🌟 Our second cohort of rising stars are set to shape the future of research, clinical practice, and patient care worldwide.
Register now to be the first to read about this year's inspiring cohort: 👉 touchcardio.com/your-free-10…
#FutureLeaders #RisingStars
🤖 How is AI moving into clinical trials and precision cardiovascular medicine?
AI is increasingly being explored across cardiovascular research and clinical care, from large language models and wearables to mobile health technologies.
At ESC Congress 2026, Dr Jazmin Aguado-Sierra discusses where these tools could add value in clinical trials and precision medicine – and why understanding their limitations and reliability is just as important as recognising their potential.
🔗 Read the full interview: touchcardio.com/insight/how-…
#ESC2026 #Cardiology #ArtificialIntelligence #PrecisionMedicine #DigitalHealth
🫀 How is pulsed field ablation changing atrial fibrillation treatment?
Atrial fibrillation ablation is evolving rapidly, with pulsed field ablation (PFA) increasingly being used alongside, and in place of, traditional thermal techniques.
At ESC Congress 2026, Prof. Jonathan Kalman discusses the rapid uptake of PFA, its potential advantages and safety profile, and which patients may benefit as the role of AF ablation continues to expand.
🔗 Read the full interview: touchcardio.com/insight/how-…
#ESC2026 #Cardiology #AtrialFibrillation #PulsedFieldAblation #Electrophysiology
🏥 Does the need for continued decongestion always mean a longer hospital stay?
Explore discharge-readiness assessment and structured outpatient or home-based diuresis for selected patients hospitalized with worsening #HeartFailure who have stabilized but still need further decongestion.
🎓 Watch the expert interview & earn CME credit 👉 touchcardioime.org/expertfoc…
#Cardiology #CME
🫀 Where do GLP-1 receptor agonists fit in heart failure care?
The role of GLP-1 receptor agonists in cardiovascular medicine continues to evolve, with growing interest in their potential role for selected patients with heart failure, particularly those with HFpEF and overweight or obesity.
At ESC Congress 2026, Prof. Adriaan Voors discusses patient selection, monitoring and the emerging evidence that could help define where these therapies fit in heart failure care.
🔗 Read the full interview: touchcardio.com/insight/wher…
#ESC2026 #Cardiology #HeartFailure #GLP1 #HFpEF #CardiovascularCare
🧬 A first-of-its-kind CAR Treg therapy has demonstrated plaque-reducing effects in a preclinical model of atherosclerosis, highlighting the growing potential of targeted immunomodulation in cardiovascular disease.
By directing Tregs against oxidised LDL (OxLDL), researchers are exploring whether this approach could help modulate inflammatory pathways that drive atherosclerotic progression.
Could OxLDL-targeted CAR Tregs represent the next step in cardio-immunotherapy?
Read more: touchcardio.com/insight/car-…
#Immunology #Atherosclerosis #CardioImmunology #CAR_Treg
🩺 Are new blood pressure technologies ready for clinical practice?
At ESC Congress 2026, Prof. George Stergiou explores the evolving role of wearable, cuffless and screening technologies for blood pressure measurement.
He discusses where these technologies could add value in clinical practice – and why accuracy and validation remain essential for clinical decision-making.
🔗 Read the full interview: touchcardio.com/insight/are-…
#ESC2026 #Cardiology #Hypertension #BloodPressure #DigitalHealth
🚀 Stay ahead in the world of Cardiology!
Get the latest research, insights, and expert opinions delivered directly to your inbox.
Sign up for our touchCARDIO newsletter and never miss a breakthrough in heart health.
🔬 From innovative treatments to clinical trial updates, we've got you covered.
💌 Join the community of healthcare professionals dedicated to making a difference.
👉 Click to subscribe now and stay informed: touchcardio.com/your-free-10…
#Cardiology #HeartHealth #MedicalNews #HealthProfessionals #Newsletter
📢 What sustains ventricular fibrillation?
Ventricular fibrillation is the arrhythmia most commonly associated with sudden cardiac arrest, yet its underlying mechanisms remain incompletely understood.
In this review, the authors explore how ventricular fibrillation evolves over time and examine the evidence supporting different mechanisms involved in its maintenance.
💡 Key discussion points:
• Why ventricular fibrillation is not simply a chaotic rhythm
• The role of re-entrant activity, focal activation and wavelet dynamics
• How mapping methods influence our understanding of ventricular fibrillation
• Future directions for personalised management and prevention
Read the full article: touchcardio.com/arrhythmia/j…
#Cardiology #Electrophysiology #VentricularFibrillation #SuddenCardiacArrest
📢 How much do patients and caregivers know about hypertension?
New research from a tertiary care centre in Northern India highlights persistent knowledge gaps around hypertension, including awareness of risk factors, blood pressure targets and routine monitoring practices.
💡 Key findings:
• Caregivers scored higher on hypertension knowledge than patients
• Regular blood pressure monitoring was reported by fewer than one-quarter of participants
• Awareness of key risk factors and complications remained limited
• Family-centred education may help improve hypertension control and outcomes
Read the full article: touchcardio.com/hypertension…
#Hypertension #Cardiology #CardiovascularHealth #BloodPressure
📢 Could a more personalised approach to ablation improve outcomes for patients with persistent atrial fibrillation (AF)?
At EHRA 2026, Dr Amir Sherwan Jadidi discusses how identifying atrial substrate abnormalities through high-density mapping in sinus rhythm may help tailor treatment strategies to the individual patient, moving beyond a one-size-fits-all approach.
The findings reinforce the growing understanding that persistent AF is a heterogeneous condition and that the extent of atrial remodelling may play an important role in determining the most effective ablation strategy.
Read the interview: touchcardio.com/insight/solv…
#EHRA2026 #Cardiology #AtrialFibrillation #AFib #Electrophysiology #HeartRhythm
How can multimodality imaging improve the diagnosis of rare cardiac complications?
This case report explores a rare presentation of native valve infective endocarditis complicated by a left ventricular abscess and pseudoaneurysm. It highlights the complementary role of echocardiography, cardiovascular magnetic resonance imaging (CMR) and cardiovascular CT angiography (CCTA) in achieving an accurate diagnosis, guiding surgical planning and supporting successful management.
Read the full case report: touchcardio.com/imaging/jour…
#Cardiology #InfectiveEndocarditis #CardiacImaging #CaseReport #Echocardiography #CMR #CCTA
📢 EHRA 2026 Highlights: Advances in Arrhythmia Management
What developments from EHRA 2026 could shape future clinical practice? ⚡️
In this expert perspective, Prof. Claudio Tondo, member of the touchCARDIO Editorial Board, reflects on key congress highlights, including advances in catheter ablation technologies, evolving approaches to persistent atrial fibrillation, innovations in device therapy and ongoing challenges in preventing sudden cardiac death.
Discover how emerging technologies and a greater focus on prevention are helping to redefine the future of arrhythmia care.
📍 Read more: touchcardio.com/insight/from…
#EHRA2026 #Cardiology #Arrhythmia #AtrialFibrillation
📢 Sudden cardiac arrest in young adults remains rare but devastating, often occurring without warning and in individuals with no known history of heart disease.
A new systematic review in Heart International examines the epidemiology, underlying causes and prevention strategies for sudden cardiac arrest in adults aged 18–40 years.
The review highlights the role of inherited and structural cardiac conditions, the value of advanced diagnostic approaches including genetic testing, and the importance of early intervention through bystander CPR, AED access and community education programmes.
Read the full review:
touchcardio.com/cardiovascul…
#Cardiology #SuddenCardiacArrest #HeartHealth #Prevention #Cardiomyopathy
📢 Is residual shunt after patent foramen ovale (PFO) closure really a key driver of recurrent stroke risk?
In a new article, Bryan Kluck challenges long-held assumptions around residual shunt following PFO closure and explores whether this commonly cited risk factor may be overestimated.
The article examines emerging evidence suggesting residual shunt may be an inadequate surrogate endpoint - and highlights why clinical focus should remain on true stroke recurrence, alongside careful consideration of post-procedural management.
Read more:
touchcardio.com/intervention…
#Cardiology #StrokePrevention #PFO #PatentForamenOvale #HeartInternational
🫀 Resistant hypertension remains a major clinical challenge, contributing significantly to adverse cardiovascular outcomes including stroke, heart failure and chronic kidney disease.
The article examines key drivers of the condition — including sympathetic nervous system overactivity, renin–angiotensin–aldosterone system dysregulation, obesity and obstructive sleep apnoea — while highlighting the importance of distinguishing true resistant hypertension from pseudo-resistance.
📄 Read the full article: touchcardio.com/hypertension…
#Hypertension #Cardiology #CardiovascularHealth #HeartHealth
❤️ How should treatment approaches for persistent atrial fibrillation be considered in older patients?
Prof Andreas Boehmer and Prof Joachim Ehrlich explore treatment strategies for older patients with persistent atrial fibrillation, including considerations around arrhythmia management, heart failure and longer-term treatment burden.
🔎 Explore their expert insights on touchCARDIO: touchcardio.com/insight/abla…
#AtrialFibrillation #Cardiology #HeartRhythm #ESC2026 #MedicalEducation
📱 eHealth & Telemonitoring in Heart Failure: Reducing Hospital Admissions
This article explores how eHealth-supported self-management and telemonitoring can improve care for patients with heart failure.
A systematic review and meta-analysis of 37 RCTs (13,366 patients) found that eHealth interventions significantly reduced HF-related hospital admissions. Impacts on mortality, quality of life, and HF knowledge were less clear, but the findings highlight the potential of telemedicine as a practical tool to support patients and optimise outcomes.
Read: touchcardio.com/heart-failur…
#HeartFailure #Telemedicine #eHealth #Cardiology
🫀 ACC26 Highlights: Imaging is redefining cardiovascular risk prevention
At ACC26, Dr. Matthew Budoff discussed how advances in cardiovascular imaging and updated cholesterol guidelines are reshaping risk assessment and preventive care.
Key themes included:
📊 The growing role of coronary artery calcium scoring in guiding treatment decisions
🎯 More individualized lipid targets based on cardiovascular risk
🩺 Greater recognition of secondary causes of hypertension
📈 How imaging may improve patient understanding, adherence and long-term prevention strategies
Explore the full ACC26 interview: touchcardio.com/insight/acc2…
#ACC2026 #Cardiology #CardiovascularDisease #PreventiveCardiology #MedicalImaging
📢 EHRA 2026: Defining the next era of arrhythmia care ⚡
EHRA 2026 showcased major advances across electrophysiology, from evolving ablation technologies to next-generation pacing strategies and new approaches to sudden cardiac death prevention.
In this expert perspective, Prof. José Luis Merino highlights some of the most impactful late-breaking trials presented at the congress, exploring how emerging evidence may influence clinical decision-making across arrhythmia management.
Key themes include advances in pulsed field ablation, conduction system pacing, implantable device innovation and increasingly personalised approaches to risk stratification and therapy selection.
Read more: touchcardio.com/insight/ehra…
#EHRA2026 #Cardiology #Electrophysiology #Arrhythmia #HeartRhythm



















